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Background: Staphylococcus aureus, especially Methicillin Resistant Staphylococcus Aureus (MRSA) is a major health
problem recognized as the most important nosocomial pathogen, often causing postoperative wound infections.
Antibiotic resistance by MRSA has grown to be common, and resistance to almost all antibiotics has been found
among these strains. The aim of this study was to determine the prevalence, antimicrobial susceptibility patterns
and associated risk factors of S. aureus in patients with surgical site infections in an Ethiopian hospital.
Methods: A cross-sectional study was conducted from December 1, 2011 to March 30, 2012 among patients with
surgical site infections at Debre Markos Referral Hospital, Debre Markos, Ethiopia. All wound swabs obtained from
patients with surgical site infections during the study period were cultured on mannitol salt agar media which is
selective for S. aureus. Isolated strains of S. aureus were tested for antibiotic susceptibility patterns using standard
disc diffusion technique, and interpretation of resistance was done based on Clinical and Laboratory Standard
Institute criteria. Univariate and multivariable analyses were used to assess the risk factors.
Results: Of the 184 surgical patients who had developed surgical site infection, S. aureus was isolated from 73
(39.7%) cases. Out of the 73 isolates of S. aureus, 36 (49.7%) were MRSA. Among the study participants, prevalence
of MRSA was found to be 19.6%. The clinical isolates showed >80% level of resistance to ampicillin, amoxicillin,
penicillin G, erythromycin, gentamicin and cotrimoxazole whereas <50% level of resistance was observed against
clindamycin, oxacillin, tetracycline and vancomycin. MRSA strains showed resistance ranging from 5.6%
(vancomycin) to 100% (cotrimoxazole). Of the following risk factors: sex, age, pus consistency, duration of operation,
type of surgery, ward and hospital stay, laparotomy type of surgery was identified as a risk factor for infection by
S. aureus.
Conclusion: The prevalence of S. aureus and/or MRSA infection in surgical and gynaecology & obstetrics wards of
Debre Markos Referral Hospital was found to be high. The majority of isolates were highly resistant to major
antimicrobial agents.
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S. aureus has been known as a cause of deep-seated
wound infection for close to a century, having been re-
cognized as a cause of nosocomial infection and super-
infection in patients receiving antimicrobial agents such as
surgical cases [1]. MRSA colonizing the anterior nares and
skin of humans are the major sources of surgical site in-
fection as well as nosocomial spread. Several trends have
been identified in the epidemiology of MRSA infections:
i) increasing incidence of MRSA infections, particularly
among surgical patients [2]; ii) increasing proportion of
nosocomial infections caused by MRSA. By the early
1990s, MRSA accounted for 20% - 25% of S. aureus iso-
lates from hospitalized patients. In 1999, MRSA accounted
for >50% of S. aureus isolates from patients in ICUs in the
National Nosocomial Infection Surveillance (NNIS) sys-
tem. In 2003, 59.5% of S. aureus isolates in NNIS ICUs
were MRSA [3,4]; and iii) increasing level of resistance to
commonly prescribed antibiotics [5]. Various risk factors
including excessive use of antibiotics and prolonged
hospitalization have been identified, which are associated
with promotion of colonization and infection to surgical
wounds as well as spread of MRSA in the health care
settings [6,7].
Data are scarce in resource-limited countries. Further-
more, isolation and antibiogram profiles require periodical
monitoring, especially in settings like Ethiopia, where sur-
gical site infection accounts for considerable morbidity
and mortality rates [8]. Unfortunately, there were no local
guidelines for prophylaxis and treatment of S. aureus in-
fection at the study area. In the study area, there had been
no previous study related to this topic. Hence, the present
study was aimed at determining the prevalence and anti-
microbial resistance pattern of S. aureus among patients
who developed surgical site infection.
Therefore, this study may help to understand the con-
tribution of S. aureus and MRSA for the development of
surgical site infection. This study can potentially identify
the high-risk groups of the study population for surgical
site infection. Moreover, it could provide useful informa-
tion that can optimize the potential benefits of isolation
and antimicrobial susceptibility testing in S. aureus and
MRSA control. It can also provide baseline information
for future research in this area.
Methods
Study area
The study was conducted at Debre Markos Referral
Hospital, Amhara Region, Ethiopia, in surgical and gy-
naecology and obstetrics wards. Debre Markos Town is
located 300 kms North-West of Addis Ababa. Debre
Markos Referral Hospital is one of the hospitals gov-
erned by Amhara Regional Health Bureau, Ethiopia, and
it serves about 3.5 million people.Swab sample and study population
This study was conducted from December 1, 2011 to
March 30, 2012. Swab samples were collected from ad-
mitted patients suspected of surgical site infections.
Inclusion criteria
Our inclusion criteria was having surgical wound with
pus discharge, serous or seropurulent discharge, signs of
sepsis (warmth, erythema, induration and pain) and with
physician diagnosis suspected of surgical site infection.
Suspected of surgical site infection mean having the
above signs and symptoms assessed by senior physicians
(surgeon and gynecologist) based on CDC criteria from
surgical and gynecology wards (there is no orthopedic
ward in the hospital).
Sample collection and handling
Following guidelines of Clinical and Laboratory Standard
Institute (CLSI), from surgical patients developing postop-
erative wound infections, swab samples were collected
from the depths of the wound using a sterile cotton swab
under an aseptic condition. Then specimens were trans-
ferred into a sterile nutrient broth in a screw caped test
tube and were delivered to the laboratory within 1 hour.
Culture and identification
The wound swabs were inoculated directly on mannitol
salt agar (Oxoid) and sub cultured to blood agar (Oxoid).
All positive cultures were identified by their characteristic
appearance on media, gram staining reactions and the
pattern of biochemical profiles using standard procedures.
S. aureus was identified based on characteristic yellow col-
ony surrounded by yellow zone on mannitol salt agar; β
hemolytic colonies with yellowish pigment on blood agar;
gram positive cocci singly in pair, in short chain or clus-
ters, catalase positive and coagulase production and man-
nitol fermentation.
Antimicrobial susceptibility testing
The antimicrobial susceptibility testing of all S. aureus
isolates were done according to the criteria of CLSI by
disc diffusion method [9].
From a pure culture, 3–5 selected colonies of S. aureus
had been taken and transferred to a tube containing
5 ml sterile nutrient broth (Oxoid) and were mixed gen-
tly. Then a homogenous suspension was formed and in-
cubated at 37°C until the turbidity of the suspension
became adjusted to a 0.5 McFarland Standard (Bacterial
concentration of 1.5 × 108 colony forming unit/ml).
A sterile cotton swab was used and the excess suspen-
sion was removed by gentle rotation of the swab against
the surface of the tube. The swab was then used to dis-
tribute the bacteria evenly over the entire surface of
Mueller Hinton plate (pH 7.2-7.4) (Oxoid).
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dry for 3–5 minutes and a set of 10 antibiotic discs (Oxoid)
with the following concentrations were then evenly distrib-
uted on the surface of a Muller Hinton plate: amoxicillin
(AML) (30 μg), ampicillin (AMP) (10 μg), penicillin G (P)
(10 mu g), erythromycin (E) (15 μg), gentamicin (CN)
(10 μg), oxacillin (Ox) (1 μg), clindamycin (DA) (2 μg),
tetracycline (TE) (30 μg), cotrimoxazole (SXT) (25 μg) and
vancomycin (VA) (30 μg). The criteria used to select the
antimicrobial agents to be tested were based on their avail-
ability and frequent prescriptions for the management of
wound infections in the hospital.
The plates were then incubated at 37°C for 24 hours.
Diameters of zones of inhibition around the discs were
measured to the nearest millimeter using a metal caliper,
and the isolates were classified as sensitive, intermediate
and resistant according to the standardized table sup-
plied by the CLSI. S. aureus ATCC 25923 was used as a
quality control for culture and antimicrobial susceptibil-
ity testing throughout the study.Table 1 Socio-demographic characteristics of patients
with surgical site infection at Debre Markos ReferralDefinitions
MRSA
A type of staphylococcus bacteria that is resistant to cer-
tain antibiotics called beta-lactams. These antibiotics in-
clude methicillin and other more common antibiotics such
as oxacillin, penicillin, and amoxicillin.Hospital, Amhara, Ethiopia [Dec. 2011-March 2012]
Variables Frequency %
Age
18-30 100 54.3Surgical site infection
An infection that occurs after surgery in the part of the








Elementary & junior 39 21.2
Secondary & above 49 26.6
Illiterate 96 52.2
ResidenceStatistical analysis
All data were analyzed using Statistical Package for Social
Sciences (SPSS) version 16. Bivariate and multivariable lo-
gistic regression model was used to ascertain the associ-
ation between the different variables and the outcome
variable with respective wadan-test to identify the possible
risk factors. All statistical tests were two-tailed, and values
of p < 0.05 were considered as statistically significant.Urban 65 35.3
Rural 119 64.7
Occupation
Governmental employee 23 12.5
Farmer 97 52.7
Student 6 3.3
House wife 53 28.8
Other 5 2.7Ethical clearance
The protocol was approved by institution of review board
of College of Health Sciences, Addis Ababa University. To
conduct this study, a letter of permission was also ob-
tained from the administration of Debre Markos Referral
Hospital. Written informed consent was obtained from
each patient. During the study period, all findings were re-
ported to the attending physicians.Results
Socio-demographic characteristics of study participants
In the present study, a total of 184 adult study partici-
pants were included: 67 from the surgical and 117 from
gynaecology & obstetrics wards. In this study, 61 (33.2%)
males and 123 (68.8%) females were participated. The
mean age was 35 years with median and standard devi-
ation of 5 and 14.4 respectively (see Table 1).Patterns of admission
Of the 67 patients from surgical ward, procedures related
to gastrointestinal problems accounted for 74.6% (50
patients), followed by gangrene of different tissues 9.0%
(6 patients), genitourinary tract problems 7.5% (5 pa-
tients), lymphoma 4.5% (3 patients), hernia accounted
for 3.0% (2 patients) and the remaining 1.5% (1 patient) was
germ cell tumor. Of the 117 obstetrics and gynecological
cases, cesarean section accounted for 82.9% (97 patients),
followed by cervical cancer 5.1% (6 patients), ovarian can-
cer 4.3% (5 patients), myoma accounted for 3.4% (4 pa-
tients) and other gynecological problems 4.3% (5 patients)
of the cases.
Table 2 Prevalence of S. aureus and MRSA in different age groups among patients with surgical site infection at Debre
Markos Referral Hospital, Amhara, Ethiopia [December, 2011 – March, 2012]
Age in
years
Surgical cases (n = 67) Gynaecology cases (n = 117) Total cases (n = 184)
S. aureus MRSA S. aureus MRSA S. aureus MRSA
no. (%) no. (%) no. (%) no. (%) no. (%) no. (%)
18-30 5 (7.5) 2 (2.9) 32 (27.4) 18 (15.4) 37 (20.1) 20 (10.9)
31-40 4 (5.9) 1 (1.5) 15 (12.8) 6 (5.1) 19 (10.3) 7 (3.8)
41-50 3 (4.5) 2 (2.9) 4 (3.4) 3 (2.6) 7 (3.8) 5 (2.7)
≥51 9 (13.4) 3 (4.5) 1 (0.8) 1(0.8) 10 (5.4) 4 (2.2)
Total 21 (31.3) 8 (11.9) 52 (44.4) 28 (23.9) 73 (39.7) 36 (19.6)
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Among the study participants, most (62%) stayed for ≤
5 days with a mean and standard deviation of 6.1 and
3.9 respectively. The length of stay in the hospital varied
from 3 to 24 days.
Prevalence of S. aureus and MRSA
Of 184 patients, 73 (39.7%) developed S. aureus infections
based on the clinical evaluations and positive wound cul-
ture results (see Table 2). Of the study participants, 21
(28.8%) were males and 52 (71.2%) were females. Out of
the 73 patients 21 (31.3%) were from surgical wards and
52 (44.4%) were from gynaecology and obstetrical wards.
Out of the 184 patients, 36 (19.6%) developed MRSA in-
fection; 28 (77.8%) of them were from gynecology and ob-
stetrical wards and the rest 8 (22.2%) were from surgical
wards (see Table 2). MRSA strains accounted for 38.1%
and 53.8% isolates from surgical patients and gynaecology
and obstetrics cases respectively. The resistance pattern of
MRSA isolates to different antimicrobials is shown in
Figure 1.
Risk factors associated with development of S. aureus
infection
Risk factors associated with development of S. aureus in-
fection were analysed using bivariate analysis with the






















Figure 1 MRSA strains showing resistance for 6 or more antimicrobia
Ethiopia [December, 2011 - March, 2012].was noted with laparotomy type of surgery (OR = 3.92,
95% CI = 1.82-8.43, p -value = 0.0001), clinical symptom
of induration (OR = 0.53, 95% CI = 0.28-0.99, p -value =
0.049) and duration of operation ≥61 minutes (OR =
2.93, 95% CI = 1.46-5.91, p -value = 0.003).
However, in multivariable logistic regression analysis, la-
parotomy type of surgery showed a significant association
with S. aureus infection. As shown in Table 3, patients who
had undergone laparotomy type of surgery were 2.03 times
more likely to develop infection with S. aureus (OR = 2.03,
95% CI = 1.91-7.01) than other types of surgery.Antimicrobial susceptibility pattern
The antimicrobial susceptibility patterns of 73 S. aureus
isolates was determined against 10 antimicrobial agents
as presented in Table 4. The majority (>80%) of the isolates
were resistant to the following antibiotics: ampicillin,
amoxicillin, penicillin G, erythromycin, gentamicin and
cotrimoxazole. S. aureus isolates showed <50% of resistance
against vancomycin, oxacillin, tetracycline and clindamycin.
However, MRSA strains showed resistance ranging from
5.6% (vancomycin) to 100% (ampicillin, amoxicillin, peni-
cillin G and cotrimoxazole). More than 40% of the MRSA
isolates showed multiple resistance (except vancomycin),
and 33.3% of these isolates showed intermediate suscepti-





l agents tested at Debre Markos Referral Hospital, Amhara,
Table 3 Bivariate and multivariable analysis of characteristics related with S. aureus isolation at Debre Markos Referral
Hospital, Amhara, Ethiopia [December, 2011 - March, 2012]
Variables Total S. aureus positive S. aureus negative COR (95% CI) p-value AOR (95% CI) p-value
Age
18-30 100 37 63 1
31-40 43 19 24 0.74 (0.35-1.53) 0.420
41-50 18 7 11 0.92 (0.32-2.58) 0.879
≥51 23 10 13 0.76 (0.30-1.91) 0.565
Sex
Female 123 52 71 1
Male 61 21 40 1.39 (0.73-2.64) 0.306
Pus consistency
Yellowish 126 58 68 1
Bloody 49 15 34 1.93 (0.95-3.89) 0.065
Duration of operation
≤30 minute 92 46 46 1 1
31-60 minute 29 11 18 1.63 (0.69-3.84) 0.258 1.40 (0.41-4.14) 0.29
≥61 minute 63 16 47 2.93 (1.46-5.91) 0.003 0.34 (0.73-2.13) 0.49
Type of surgery
Caesarean section 86 44 42 1 1
Laparotomy 57 12 45 3.92 (1.82-8.43) 0.0001 2.03 (1.91-7.01) 0.03
Appendectomy 12 5 7 1.46 (0.43-4.98) 0.539 0.78 (0.08-7.65) 0.83
Hysterectomy 9 4 5 1.31 (0.32-5.21) 0.702 0.56 (0.05-5.74) 0.62
Prostectomy 4 2 2 1.04 (0.14-7.78) 0.964 0.01 (0.91-8.01) 0.99
Salphangectomy 3 1 2 2.09 (0.18-3.97) 0.552 1.40 (0.06-17.98) 0.95
Others 13 5 8 1.67 (0.50-5.53) 0.397 0.03 (0.11-11.30) 0.99
Induration
No 69 21 48 1 1
Yes 115 52 63 0.53 (0.28-0.99) 0.049 0.60 (0.31-1.17) 0.14
Ward
Surgical 67 21 46 1
Gynaecology 117 52 65 0.57 (0.30-1.07) 0.082
Hospital stay
≤5 days 114 49 65 1
6-10 days 55 18 37 1.55 (0.78-3.04) 0.203
11-15 days 5 1 4 3.01 (0.32-27.83) 0.330
≥16 days 10 5 5 0.75 (0.20-2.74) 0.669
1= reference category induration- a focus or region of abnormally hardened tissue.
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36 (49.3%) were found to show resistance to oxacillin and
hence defined as MRSA isolates. MRSA isolates from sur-
gical patients as well as gynaecology and obstetrics cases
showed multiple resistances (≥6 antimicrobial).
Discussion
The development and treatment of surgical wound in-
fections have always been limiting factors to the successof surgical treatment. Although continuous improve-
ments have been made, surgical site infections continue
to occur at an unacceptable rate, annually costing bil-
lions of dollars in economic loss caused by associated
morbidity and mortality [8]. S. aureus has long been rec-
ognized as an important pathogen in human disease and
is the most common cause of nosocomial infections [1].
A study conducted on a murine model showed that
laparotomy type of surgery had a statistically significant
Table 4 Antimicrobial susceptibility pattern of S. aureus and MRSA from patients with surgical site infection at Debre
Markos Referral Hospital, Amhara, Ethiopia [December, 2011 - March, 2012]
S. aureus (n = 73) MRSA (n = 36)
Antimicrobial agent Sensitive no. (%) Intermediate no. (%) Resistant no. (%) Sensitive no. (%) Intermediate no. (%) Resistant no (%)
Ampicillina 13 (17.8) - 60 (82.2) - - 36 (100)
Amoxicillina 13 (17.8) - 60 (82.2) - - 36 (100)
Erythromycina - 3 (4.1) 70 (95.9) - 1 (2.8) 35 (97.2)
Gentamicina 9 (12.3) - 64 (87.7) 2 (5.6) - 34 (94.4)
Tetracyclinea 37 (50.7) 12 (16.4) 24 (32.9) 12 (33.3) 9 (25) 15 (41.7)
Penicillin Ga 13 (17.8) - 60 (82.2) - - 36 (100)
Clindamycina 7 (9.6) 31 (42.4) 35 (47.9) 2 (5.6) 12 (33.3) 22 (61.1)
Cotrimoxazolea 1 (1.4) 1 (1.4) 71 (97.2) - - 36 (100)
Vancomycina 70 (95.9) - 3 (4.1) 34 (94.4) - 2 (5.6)
Oxacillina 37 (50.7) - 36 (49.3) - - 36 (100)
aClinical and Laboratory Standards Institute (CLSI) breakpoint for Staphylococcus spp.
AMP: ampicillin, AML: amoxicillin, P: penicillin G, CN: gentamicin, E: erythromycin, Ox: oxacillin, TE: tetracycline, DA: clindamycin, SXT: cotrimoxazole,
VA: vancomycin.
Intermediate resistant: The “intermediate” category includes isolates with antimicrobial MICs that approach usually attainable blood and tissue levels and for
which response rates may be lower than for susceptible isolates (CLSI definition).
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this, the present finding also showed that the odds of fa-
voring S. aureus infection in cases undergone laparot-
omy type of surgery was 2.03 times more than other
types of surgery (see Table 3). This could be explained
by this type of surgery which had open wound and can
easily be contaminated by this bacterium.
Greater than 80% of resistance was observed to ampi-
cillin, amoxicillin, penicillin G, gentamicin, erythromycin
and cotrimoxazole among S. aureus isolates (see Table 4).
Many factors may have contributed to such level of re-
sistance, including misuse of antibiotics by health profes-
sionals, unskilled practitioners and lay persons. In Debre
Markos it is a common practice that antibiotics can be
purchased without prescription, which leads to misuse
of antibiotics by the public, thus contributing to the
emergence and spread of antimicrobial resistance. Other
causal factors could be poor hospital hygienic condi-
tions, accounting for the spread of resistant bacteria and
inadequate surveillance, i.e. lack of information from
routine antimicrobial susceptibility testing of bacterial
isolates and surveillance testing of bacterial isolates and
surveillance of antibiotic resistance, all of which are cru-
cial for good clinical practice and for rational policies
against antibiotic resistance [4]. Whereas <50% of resist-
ance was observed by S. aureus isolates against vanco-
mycin, oxacillin, tetracycline and clindamycin from all
wards, in agreement with previous reports in Ethiopia
and India [11,12].
All MRSA isolates encountered in this study were
completely resistant to antibiotics, such as cotrimoxazole
and erythromycin. A similar result was noted for
erythromycin among MRSA strains from Trinidad andNew York [13,14]. Similarly a comparable result was re-
ported for cotrimoxazole in Islamabad [15].
The resistance rate of MRSA isolates to vancomycin
was found to be 5.6% (see Table 4). This result was
higher when compared to previous findings from differ-
ent parts of the world, including Ethiopia. These reports
revealed that there is no MRSA isolate resistance to
vancomycin [11,15,16]. This variation may be due to
timely emergence of resistance strains. However, our re-
sult is lower in contrast to report from New York (10%)
[2]. This lower finding may be explained by method vari-
ation, since assessment of the previous study was in a
controlled clinical trial.
In this study, high prevalence of multidrug resistant
MRSA was observed. This may predispose patients to in-
fection with intractable isolates and emphasizing the need
for improved infection control practices and guidelines
for use of antibiotics in this setting. Moreover, all MRSA
strains isolated in our investigation were resistant to ≥3 an-
tibiotics tested excluding β lactams (penicillin G, ampicil-
lin, amoxicillin). Arora et al. revealed that, 73% of MRSA
strains were multidrug resistant [17]. This indicated that
resistant strains were emerged and the emergence of those
resistant strains, especially for the most bactericidal anti-
MRSA agents, may have further aggravated the emergence
of multidrug resistant MRSA, and it may threaten the suc-
cess of an MRSA control program. Molecular confirm-
ation of MRSA strains was not conducted due to absence
of molecular techniques in the study set up.
Conclusions
The prevalence of S. aureus and MRSA in surgical and gy-
naecology and obstetrics wards of Debre Markos Referral
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strains among clinical isolates was also high. Vanco-
mycin was relatively effective drug for S. aureus and
MRSA infections. High level of resistance was observed
to erythromycin, cotrimoxazole and gentamycin among
S. aureus isolates from surgical ward. In addition, high
level of resistance was observed to erythromycin, cotri-
moxazole, gentamycin, ampicillin, amoxicillin and penicil-
lin G among isolates from gynaecology and obstetrics
ward. Moreover, all MRSA isolates were multidrug resist-
ant (≥6). As a recommendation, the rationale of some
antibiotic combinations requires evaluation and the estab-
lishment of antibiotic policy and treatment guidelines.
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